TheProfitWatch

ABEO - Abeona Therapeutics Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
4.3 0.21 (4.82%) 0.0 (0.0%) 0.0 (0.0%) -0.01 (-0.22%) 0.0 (0.05%) 0.29 (7.01%) 0.0 (0.0%) 0.13 (3.12%)

Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Market

Earnings & Ratios

Basic EPS:
2.07
Diluted EPS:
1.71
Basic P/E:
2.1763
Diluted P/E:
2.6345
RSI(14) 1m:
66.67
VWAP:
4.5
RVol:

Events

Period Kind Movement Occurred At

Related News